3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
24
Neoplasm Metastasis
5
Triple Negative Breast Neoplasms
2
Recurrence
2
Ovarian Neoplasms
2
Multiple Endocrine Neoplasia Type 1
2
Lymphatic Abnormalities
2
Lymphangioma, Cystic
2
Lymphangioma
2
Hyperglycemia
2
Hereditary Sensory and Autonomic Neuropathies
2
Vascular Malformations
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Diseases, Vascular
1
Melanoma
1
Hormone Receptor Positive Breast Carcinoma
1
Head and Neck Squamous Cell Cancer
1
Head and Neck Neoplasms
1
HER2-positive Metastatic Breast Cancer
1
Genetic Diseases, Inborn
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Arteriovenous Malformations
1
Advanced HER2+Breast Cancer
1
Advanced Breast Cancer
1
Interventions
Cisplatin
32
Radiotherapy, Intensity-Modulated
21
Magnetic Resonance Spectroscopy
21
Radiotherapy
16
Specimen Handling
15
Radiation
14
Carboplatin
14
pembrolizumab
13
Platinum
12
1,2-diaminocyclohexaneplatinum II citrate
11
Paclitaxel
8
Chemoradiotherapy
7
Biopsy
7
Taxes
6
Surveys and Questionnaires
6
Cetuximab
6
Nivolumab
5
Surgical Procedures, Operative
4
Observation
4
Fluorodeoxyglucose F18
4
Drug Therapy
4
Docetaxel
4
durvalumab
3
(225)Ac-DOTA-c(RGDyK)
3
toripalimab
2
cemiplimab
2
atezolizumab
2
aldesleukin
2
X-Rays
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Oropharyngeal Neoplasms
×
Alpelisib
×
1 year
×
Clear all
No trials found.